AEON Biopharma, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net income was USD 38.88 million compared to net loss of USD 10.44 million a year ago.
For the nine months, net income was USD 5.86 million compared to net loss of USD 17.99 million a year ago.